Pfizer JKI 5 (Xeljanz 5 mg)
Generic Name: tofacitinib
Pill with imprint Pfizer JKI 5 is White, Round and has been identified as Xeljanz 5 mg. It is supplied by Pfizer, Inc.
Xeljanz is used in the treatment of ulcerative colitis; ankylosing spondylitis; rheumatoid arthritis; psoriatic arthritis; juvenile idiopathic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer JKI 5
Xeljanz
- Generic Name
- tofacitinib
- Imprint
- Pfizer JKI 5
- Strength
- 5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer, Inc.
- National Drug Code (NDC)
- 00069-1001
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
magnesium stearate,
titanium dioxide,
triacetin,
polyethylene glycol 3350,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
More about Xeljanz (tofacitinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (126)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: antirheumatics
- Latest FDA Alerts (4)
- FDA approval history
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.